Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical EGF Cream for EGFR Inhibitor-Related Skin Reactions
NCT03047863Unknown
- Sponsor
- The Catholic University of Korea
- Start
- Nov 2016
- Primary completion
- Aug 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, double-blind trial in acneiform eruption comparing Repair Control EGF with Placebo (2 arms). Primary endpoint: The change of severity of acneform eruption induced by EGFR inhibitors at 4 weeks. Status: unknown.
02
Drugs
nepidermin
03
Conditions
acneiform eruption
Beyond the preview
Go deeper on NCT03047863.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03047863.